Death or reinfarction
is delayed by more than one year with a primary percutaneous coronary intervention (PCI) strategy that includes hospital transfer, compared to fibrinolysis, according to late breaking results from the DANAMI-2 trial presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology(1) and published in European Heart Journal.(2)
In the 12 months of follow-up, cardiac death, target vessel myocardial reinfarction
, clinically indicated target lesion revascularization, and definite stent thrombosis were similar between the treatment groups.
Effects of timing, location and definition of reinfarction
on mortality in pts with totally occluded infarct related arteries late after myocardial infarction.
Special attention was paid to the patients' hospitalization course which was considered as eventful if the patient developed significant arrhythmias, post-infarction angina, reinfarction
, heart failure, stroke, or death.
However, patients who were diagnosed with STEMI or NSTEMI had no significant difference in reinfarction
(all P > 0.05) and TVR (all P > 0.05) in the intervals of 0-1 month as well as 1 month to 1 year.
Risk of death or reinfarction
associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Therefore, an oral surgery should be postponed in patients with arterial coronary disease, due to the high risk of reinfarction
and cardiac arrest .
In their study of 1079 AMI patients, these authors analyzed the associations of TMAO with all-cause mortality or reinfarction
in comparison with other biomarkers [including N-terminal pro-B-type natriuretic peptides (NT-proBNP)].
van der Horst et al., "Cardiac death and reinfarction
after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study," The Lancet, vol.
Numerous treatment methods based on the pathogenesis and related to timely reperfusion [5, 6] and reinfarction
or ventricular remodelling reduction in the later stage of MI using pharmacological agents have flourished recently .
Door-to-balloon Door-to-balloon Outcome < 60 min 60~90min aOR 95% CI Reference TIMI flow < 3 * 0.4 0.20-0.76 1 30-day reinfarction
0.3 0.10-0.91 1 30-day mortality 0.3 0.09-0.77 1 * TIMI flow < 3: thrombolysis in myocardial infarction (TIMI) flow < 3.
Secondary Prevention Reinfarction
Israeli Nifedipine Trial.